On ECHEMI
Home > Drugs > Phentolamine Mesylate Tablets

Phentolamine Mesylate Tablets

Function and Efficacy

This product is an alpha adrenergic receptor blocker that acts on both alpha 1 and alpha 2 receptors, dilating blood vessels and thus reducing peripheral vascular resistance. The mechanism of action of this product in treating male erectile dysfunction may be to dilate the penile artery vessels, increase the blood flow of the cavernous body, thereby improving the penile erectile function, increasing the hardness of the penis, and prolonging the duration of erection.

Ingredients

3-[[(4,5-dihydro-1H-imidazol-2-yl)methyl](4-methylphenyl)amino]phenol methanesulfonate

Appearance

This product is white or off-white tablets.

Indication

Used to treat male erectile dysfunction.

Usage and Dosage

Oral administration, one tablet (40 mg) each time, 30 minutes before sexual intercourse, up to once a day. The dose can be adjusted to 60 mg according to needs and tolerance.

Adverse Reactions

Common symptoms include nasal congestion, headache, dizziness, flushed face, indigestion, diarrhea, urinary tract infection, fatigue, chest tightness, one-time mild hallucinations and rash; a small number of patients may have palpitations, tachycardia, arrhythmia, fatigue, nausea and vomiting, hypotension; very few patients may suffer from orthostatic hypotension.

Precautions

It is contraindicated for patients with hypotension, severe arteriosclerosis, organic heart damage, renal insufficiency, gastric and duodenal ulcers, and those who are allergic to this product.

Special Population Medication

Precautions for children: This product is not suitable for children. Precautions for pregnancy and lactation: This product is not suitable for pregnant and lactating women. Precautions for the elderly: The possibility of hypothermia inducing by the elderly is increased.

Drug Interactions

1. When used in combination with sympathomimetic amines, the latter's peripheral vasoconstriction effect is offset or weakened; 2. When used in combination with guanethidine, the incidence of orthostatic hypotension or bradycardia increases; 3. When used in combination with diazoxide, the inhibitory effect of diazoxide on insulin release is inhibited; 4. Sedative hypnotics such as phenobarbital and doxepin and antihypertensive drugs such as reserpine and jiangyaling can enhance the antihypertensive effect of this product; 5. When used in combination with cardiac glycosides, its toxic reactions can be enhanced; 6. Avoid use with iron preparations; 7. This product cannot be used in combination with nitroglycerin drugs.

Storage

Keep in a sealed container and shield from light. The validity period is tentatively set at two years.

Packaging Specification

40mg

Validity Period

Tentative 24 months

Manufacturer

Zhejiang Jolly Pharmaceutical Co., Ltd.

  • Founded in:

    2000-01-28
  • Address:

    No. 388, Zhiyuan North Road, Fuxi Street, Deqing County, Zhejiang Province
  • Tax NO.:

    91330000147115443M
  • Registered Funds:

    701.387335 million yuan
  • Website:

  • Email:

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.